摘要
癌症患者通常与各种生理和心理症状有关。在缓和的环境下,目的是缓解这些症状,改善生活质量,增加癌症患者的药物依从性。抗抑郁药被普遍接受用于治疗癌症患者的抑郁症。抗抑郁药的一些其他潜在的好处已经在癌症患者中被报道。 目的:本研究旨在回顾抗抑郁药在癌症患者的生理和心理症状中的应用。 结果:我们的研究结果显示,与癌症患者相关的各种症状的阳性和阴性结果是混合的,这些研究是按照从高到低水平的证据层次分类的,即随机对照试验、队列研究、病例对照研究、病例系列、病例报告以及其他类型的证据。大多数用于癌症患者的抗抑郁药物似乎对抑郁症、焦虑、潮热和其他症状如性功能障碍、疲劳、尼古丁依赖、血管运动症状、执行功能、睡眠问题、瘙痒以及疑病症的治疗都是有益的。虽然氟西汀被发现与恩丹西酮的止吐作用减少有关,米氮平被认为是治疗癌症患者恶心和恶病质的良好选择。 结论:有必要进行更多具有足够统计力的研究,以验证癌症患者使用抗抑郁药治疗这些生理和心理症状的有效性。
关键词: 抗抑郁,焦虑,恶心,恶病质,潮热,疼痛,癌症。
Current Drug Targets
Title:The Use of Antidepressants for Physical and Psychological Symptoms in Cancer
Volume: 19 Issue: 12
关键词: 抗抑郁,焦虑,恶心,恶病质,潮热,疼痛,癌症。
摘要: Cancer patients are commonly associated with various physical and psychological symptoms. In palliative setting, the aims are to relieve those symptoms, improve quality of life, and increase medication adherence among cancer patients. Antidepressants are generally accepted for the treatment of depression among patients with or without cancer. Some other potential benefits of the antidepressants have been reported in cancer patients.
Objective: This study aims to review the use of antidepressants for physical and psychological symptoms in cancer patients.
Results: Our findings showed the mixed result of positive and negative findings in various symptoms associated with cancer patients. These studies are categorised according to the hierarchy of evidence from high to low level, namely randomised controlled trials, cohort studies, case-control studies, case series, case reports, as well as other type of publications. The majority of antidepressants used in cancer patients seem to be beneficial for the treatment of depression, anxiety, hot flashes and other symptoms such as sexual dysfunction, fatigue, nicotine dependence, vasomotor symptoms, executive functions, sleep problems, pruritus, as well as for hypochondriasis. While fluoxetine was found to be associated with the reduction of antiemetic property in ondansetron, mirtazapine was identified to be a good alternative in treating nausea and cachexia among cancer patients.
Conclusion: More research studies with adequate statistical power are warranted to validate the use of antidepressants among cancer patients in treating these physical and psychological symptoms.
Export Options
About this article
Cite this article as:
The Use of Antidepressants for Physical and Psychological Symptoms in Cancer, Current Drug Targets 2018; 19 (12) . https://dx.doi.org/10.2174/1389450119666180226125026
DOI https://dx.doi.org/10.2174/1389450119666180226125026 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Occupational Complexity and Leisure Activities in Cognitive Aging
Current Psychopharmacology Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Current Medicinal Chemistry Use of Benzodiazepines and Haloperidol Among Orthopedic Patients in Postoperative Delirium. A Systematic Review
Current Psychopharmacology Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Recent Development of Radioligands for Imaging α7 Nicotinic Acetylcholine Receptors in the Brain
Current Topics in Medicinal Chemistry Impedance based Microfluidic Biosensor for Cell Study
Micro and Nanosystems Co-Induction of CYP3A12 and 3A26 in Dog Liver Slices by Xenobiotics: Species Difference Between Human and Dog CYP3A Induction
Drug Metabolism Letters Respiratory Gas Exchange During Exercise in Children with Congenital Heart Disease: Methodology and Clinical Concepts
Current Respiratory Medicine Reviews Synthesis of Novel Fluorine Compounds Substituted-4-thiazolidinones Derived from Rhodanine Drug as Highly Bioactive Probes
Current Organic Synthesis Oxidative Stress and Lipid Peroxidation in Prolonged Users of Methamphetamine
Drug Metabolism Letters Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis
Current Medicinal Chemistry How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications
CNS & Neurological Disorders - Drug Targets Role of Autophagy in Parkinson’s Disease
Current Medicinal Chemistry Brain-derived Neurotrophic Factor Genetic Variants are Associated with Major Depression Susceptibility and Serotonin Reuptake Inhibitor Antidepressant Treatment Response in Taiwanese
Current Pharmacogenomics and Personalized Medicine Deep Brain Stimulation for Alzheimer’s Disease
Current Alzheimer Research Skeletal Muscle Cell Behavior After Physical Agent Treatments
Current Pharmaceutical Design Therapeutic Relevance of the Allosteric Modulation of the 5-HT Transporter
Current Signal Transduction Therapy Signaling Mechanisms Underlying Aβ Toxicity: Potential Therapeutic Targets for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets